Helus Pharma Inc. (HELP) Financials

HELP Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 259.3 million 17.5 million
March 31, 2026 350.3 million 27.0 million
Dec. 31, 2025 289.9 million 16.2 million
Sept. 30, 2025 252.8 million 58.9 million

HELP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -36.4 million ?
March 31, 2026 -37.1 million 3.8 million
Dec. 31, 2025 -32.3 million 4.5 million
Sept. 30, 2025 -48.7 million 525813

HELP Net Income

No data available :(

HELP Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 166.2 million - -
March 31, 2026 219.3 million - -
Dec. 31, 2025 195.0 million - -
Sept. 30, 2025 116.8 million 40.3 million -

HELP Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 36.8 million
March 31, 2026 36.1 million
Dec. 31, 2025 17.7 million
Sept. 30, 2025 17.4 million

HELP Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 311873 30.0 million 17.8 million -
March 31, 2026 318414 28.9 million 19.0 million 4.6 million
Dec. 31, 2025 382687 23.8 million 17.3 million 1.1 million
Sept. 30, 2025 608102 26.3 million 14.0 million 486760

HELP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 30212
March 31, 2026 931530 21922
Dec. 31, 2025 - 22356
Sept. 30, 2025 - 28725

HELP

Price: $11.42

52 week price:
3.76
15.15

Earnings Per Share: -4.10 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 725.2 million

Links: